Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 5/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.35 |
| ▸ | EGLN3 | Q9H6Z9 | 2/20 | 0.35 |
| ▸ | AR | P10275 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10124652 | 0.92 | GAA (0.42) | ELANEPOLBNPC1RAB9ALMNA | |
| SCHEMBL10124655 | 0.92 | GAA (0.42) | ELANEPOLBNPC1RAB9ALMNA | |
| SCHEMBL10124648 | 0.90 | ELANE (0.41) | ELANEPOLBNPC1RAB9ALMNA | |
| SCHEMBL10124651 | 0.83 | POLB (0.42) | ELANEPOLBNPC1RAB9ALMNA | |
| SCHEMBL10124662 | 0.82 | POLB (0.36) | POLBNPC1RAB9ALMNAMAPT | |
| SCHEMBL18697263 | 0.81 | POLB (0.40) | ELANEPOLBNPC1RAB9ALMNA | |
| SCHEMBL10124669 | 0.78 | POLB (0.34) | POLBNPC1RAB9AMAPTAR | |
| SCHEMBL11483851 | 0.78 | POLB (0.45) | ELANEPOLBNPC1RAB9ALMNA | |
| SCHEMBL10124680 | 0.78 | ELANE (0.38) | ELANEPGRMAPTNPSR1GAA | |
| SCHEMBL10124673 | 0.78 | POLB (0.41) | ELANEPOLBNPC1RAB9ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9045480-B2 | Sterically hindered amine light stabilizers | BASF SE (DE) | 2015-06-02 | — | — | US | disclosed |
| US-20120108709-A1 | NOVEL STERICALLY HINDERED AMINE LIGHT STABILIZERS | BASF SE (DE) | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108709-A1 | NOVEL STERICALLY HINDERED AMINE LIGHT STABILIZERS | AAAS, CRY1, TAAR1 | ELANE 2936/4885POLB 1620/4885NPC1 2178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.